Neutrophil elastase enhances antigen presentation by upregulating human leukocyte antigen class I expression on tumor cells

作者:Chawla Akhil; Alatrash Gheath*; Philips Anne V; Qiao Na; Sukhumalchandra Pariya; Kerros Celine; Diaconu Iulia; Gall Victor; Neal Samantha; Peters Haley L; Clise Dwyer Karen; Molldrem Jeffrey J; Mittendorf Elizabeth A*
来源:Cancer Immunology, Immunotherapy, 2016, 65(6): 741-751.
DOI:10.1007/s00262-016-1841-6

摘要

Neutrophil elastase (NE) is an innate immune cell-derived inflammatory mediator that we have shown increases the presentation of tumor-associated peptide antigens in breast cancer. In this study, we extend these observations to show that NE uptake has a broad effect on enhancing antigen presentation by breast cancer cells. We show that NE increases human leukocyte antigen (HLA) class I expression on the surface of breast cancer cells in a concentration and time-dependent manner. HLA class I upregulation requires internalization of enzymatically active NE. Western blots of NE-treated breast cancer cells confirm that the expression of total HLA class I as well as the antigen-processing machinery proteins TAP1, LMP2, and calnexin does not change following NE treatment. This suggests that NE does not increase the efficiency of antigen processing; rather, it mediates the upregulation of HLA class I by stabilizing and reducing membrane recycling of HLA class I molecules. Furthermore, the effects of NE extend beyond breast cancer since the uptake of NE by EBV-LCL increases the presentation of HLA class I-restricted viral peptides, as shown by their increased sensitivity to lysis by EBV-specific CD8+ T cells. Together, our results show that NE uptake increases the responsiveness of breast cancer cells to adaptive immunity by broad upregulation of membrane HLA class I and support the conclusion that the innate inflammatory mediator NE enhances tumor cell recognition and increases tumor sensitivity to the host adaptive immune response.

  • 出版日期2016-6